MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Net loss-$30,032K (-90.68%↓ Y/Y)Loss before incometaxes-$30,016K (-90.66%↓ Y/Y)Provision for income taxes$16K (128.57%↑ Y/Y)Interest income$2,172K (7.15%↑ Y/Y)Pharma TestingServices$10,724K Population Sequencing$2,500K (-40.66%↓ Y/Y)Clinical Diagnostic$1,431K (364.61%↑ Y/Y)Other$424K (1596.00%↑ Y/Y)Enterprise Sales$393K (-84.06%↓ Y/Y)Other income(expense), net$20K (143.48%↑ Y/Y)Loss from operations-$32,161K (-81.74%↓ Y/Y)Revenue$15,472K (-24.91%↓ Y/Y)Interest expense$47K (67.86%↑ Y/Y)Total costs andexpenses$47,633K (24.36%↑ Y/Y)Selling, general andadministrative$17,903K (45.99%↑ Y/Y)Cost of revenue$15,191K (13.38%↑ Y/Y)Research and development$14,539K (15.02%↑ Y/Y)
Income Statement
source: myfinsight.com

Personalis, Inc. (PSNL)

Personalis, Inc. (PSNL)